Premium
Oric Pharmaceuticals Inc (ORIC)
NASDAQ
Hot Features
Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
| Date | Nom du détenteur | Actions transigées | Fourchette de valeur ($) | Type d'opération | Fourchette de prix ($) | Actions en fin de déclaration | % de variation |
|---|---|---|---|---|---|---|---|
| 2026-02-24 | Mr. Dominic G. PiscitelliCFO | -52,00k | 475,97k | Derivative Exercise and Sale | 4,36 - 13,51 | 68,15k | - |
| 2026-01-16 | Dr. Richard A. HeymanFounder, Independent Chairman & Member of Scientific Advisory Board | -6,70k | 80,43k | Automatic Disposition | 12,00 | 254,87k | -2,56% |
| 2025-12-15 | Dr. Pratik S. MultaniChief Medical Officer | -10,72k | 97,13k | Derivative Exercise and Sale | 9,06 | 68,15k | - |
| 2025-12-15 | Dr. Pratik S. MultaniChief Medical Officer | 18,61k | 0,00 | Derivative Exercise and Retained Stock | - | 68,15k | 37,57% |
| 2025-12-15 | Mr. Dominic G. PiscitelliCFO | 18,61k | 0,00 | Derivative Exercise and Retained Stock | - | 68,15k | 37,58% |
| 2025-12-15 | Mr. Dominic G. PiscitelliCFO | -10,72k | 97,13k | Derivative Exercise and Sale | 9,06 | 68,15k | - |
| 2025-12-15 | Dr. Jacob M. ChackoPresident, CEO & Director | 50,29k | 0,00 | Derivative Exercise and Retained Stock | - | 581,71k | 9,46% |
| 2025-12-15 | Dr. Jacob M. ChackoPresident, CEO & Director | -33,37k | 302,37k | Derivative Exercise and Sale | 9,06 | 581,71k | - |
| 2025-12-08 | Dr. Lori Anne KunkelIndependent Director | 10,00k | 79,00k | Derivative Exercise and Retained Stock | 7,90 | 84,20k | 13,48% |
| 2025-12-04 | Dr. Lori Anne KunkelIndependent Director | 5,53k | 20,75k | Derivative Exercise and Retained Stock | 3,75 | 74,20k | 8,06% |
| 2025-10-06 | Mr. Dominic G. PiscitelliCFO | -11,00k | 111,76k | Derivative Exercise and Sale | 4,36 - 14,52 | 48,32k | - |
| 2025-10-06 | Dr. Jacob M. ChackoPresident, CEO & Director | -37,46k | 461,52k | Automatic Disposition | 12,32 | 531,42k | -6,59% |
| 2025-10-03 | Dr. Richard A. HeymanFounder, Independent Chairman & Member of Scientific Advisory Board | 32,80k | 55,59k | Derivative Exercise and Retained Stock | 1,60 - 3,75 | 261,57k | 14,34% |
| 2025-09-30 | Dr. Jacob M. ChackoPresident, CEO & Director | -87,54k | 1,05M | Automatic Disposition | 12,01 - 12,05 | 568,88k | -13,34% |
| 2025-09-22 | Dr. Jacob M. ChackoPresident, CEO & Director | -125,00k | 1,35M | Automatic Disposition | 10,80 | 656,42k | -16,00% |
| 2025-07-01 | Mr. Dominic G. PiscitelliCFO | -20,00k | 200,97k | Automatic Disposition | 10,05 | 48,32k | -29,28% |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
